Poor
Mostly Unaligned
Patient Risk:
Low
Summary
Most claims are about generic drug pricing/availability/insurance coverage and generic market history, which are not addressed in the provided CRESTOR prescribing information excerpts. No on-label efficacy, dosing, contraindications, boxed warnings, or specific safety/administration claims are evaluated; therefore alignment to the supplied label is largely unsupported/absent.
Category Scores
Accurate Statements
Rosuvastatin is available in strengths including 5 mg, 10 mg, 20 mg, and 40 mg tablets.
DOSAGE FORMS AND STRENGTHS (3): CRESTOR tablets include 5 mg, 10 mg, 20 mg, 40 mg.
The prescribed dosage of rosuvastatin depends on an individual's cholesterol levels and individual risk for CV events.
DOSAGE AND ADMINISTRATION (2.2): recommended dosage depends on indication for usage, LDL-C, and individual risk for CV events.
Unsupported Statements
The price of generic Crestor (rosuvastatin) varies depending on dosage, quantity, pharmacy, and insurance coverage.
Not supported by the provided prescribing information excerpts (label does not discuss pricing determinants).
Online pharmacies and prescription discount programs can offer significantly lower prices for generic rosuvastatin compared with traditional brick-and-mortar pharmacies.
Not supported by the provided prescribing information excerpts (label does not discuss pricing sources or discount programs).
The cost of rosuvastatin can range from under $10 to over $100 for a 30-day supply.
Not supported by the provided prescribing information excerpts (no cost ranges are provided).
A 30-day supply of 10 mg rosuvastatin tablets might cost around $15 to $30 without insurance at some discount pharmacies.
Not supported by the provided prescribing information excerpts (no specific retail cost estimates).
Higher dosages or larger quantities of rosuvastatin may have proportionally higher costs.
Not supported by the provided prescribing information excerpts (no relationship between dose/quantity and cost is described).
The per-unit price of rosuvastatin often decreases with larger quantities.
Not supported by the provided prescribing information excerpts.
Prices for rosuvastatin can fluctuate based on market competition and availability.
Not supported by the provided prescribing information excerpts.
Insurance plans often cover generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Copay amounts for generic rosuvastatin differ by insurance plan.
Not supported by the provided prescribing information excerpts.
Some insurance plans may require a small copay for generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Some insurance plans may require a deductible to be met first before covering generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Checking with an insurance provider or their online formulary is the best way to determine out-of-pocket cost for generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Prescription discount cards and coupons can often lower the cost of rosuvastatin significantly.
Not supported by the provided prescribing information excerpts.
Many online pharmacies offer competitive pricing on generic medications, sometimes with free shipping.
Not supported by the provided prescribing information excerpts.
Rosuvastatin became available as a generic medication after the patent protection for branded Crestor expired.
Not supported by the provided prescribing information excerpts (no patent/generic availability history is provided).
The U.S. patent for Crestor expired in 2016.
Not supported by the provided prescribing information excerpts.
The expiration of Crestor's U.S. patent led to the introduction of generic versions by multiple pharmaceutical manufacturers.
Not supported by the provided prescribing information excerpts.
The introduction of generic versions typically results in a substantial price decrease for the drug.
Not supported by the provided prescribing information excerpts.
Numerous pharmaceutical companies manufacture generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Teva Pharmaceuticals manufactures generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Mylan (now Viatris) manufactures generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Aurobindo Pharma manufactures generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Apotex manufactures generic rosuvastatin.
Not supported by the provided prescribing information excerpts.
Higher dosages or larger quantities of rosuvastatin may have proportionally higher costs.
Not supported by the provided prescribing information excerpts (already covered above; no label basis).
Contradictions
Important Omissions
No label-based safety, dosing instructions, contraindications, boxed warnings, drug interactions, or monitoring information were provided alongside the pricing/market-history claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The provided claims are primarily about pricing/insurance/patent history rather than prescribing decisions. Only two statements map to label excerpts (strengths; dosage dependence on LDL-C and individual CV risk). However, many unsupported claims could mislead users about cost/coverage without informing label-relevant safety or dosing.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Unaligned
Primary Issue
Claims focus on generic pricing, insurance coverage, and patent/generic manufacturer history, none of which are addressed in the provided FDA-approved CRESTOR prescribing information excerpts.
Suggested Improvement
Limit statements to label-supported information from the provided excerpts (e.g., available tablet strengths and that recommended dosage depends on indication, LDL-C, and individual CV risk). Avoid specific price ranges and manufacturer/patent timing assertions unless supported by label content (none provided here).